Pricing Log in Create free account

Caribou Biosciences, Inc. (CRBU) vs Hyperion DeFi, Inc. (HYPD)

Caribou Biosciences, Inc. and Hyperion DeFi, Inc. are both Biotechnology companies. Caribou Biosciences, Inc. and Hyperion DeFi, Inc. are of similar size ($49.8M and $49.0M). Hyperion DeFi, Inc. grew revenue faster over the last twelve months: 1,990.6% against 10.0%. Caribou Biosciences, Inc. has the higher net margin (−1,030.4% vs −1,224.5%) and the lower return on invested capital (0.00% vs 2.73%). Across the 18 metrics below, Hyperion DeFi, Inc. leads on 10 and Caribou Biosciences, Inc. on 8.

Valuation

Metric CRBU HYPD Biotechnology median
P/E n/m n/m 8.50
P/S 4.73 28.74 9.71
P/B 0.48 0.39 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.60 7.98 0.64
EV/Sales (6.46) 27.88 9.21
Earnings yield (229.79%) (217.96%) (33.15%)
Free cash flow yield (279.78%) (191.71%) (25.50%)

Profitability

Metric CRBU HYPD Biotechnology median
Gross margin 100.00% 78.35% 65.16%
Operating margin (1,090.90%) 314.32% 0.00%
Net margin (1,030.42%) (1,224.53%) 0.00%
Free cash flow margin (1,323.30%) (5,509.35%) 0.00%
Return on equity (78.27%) (24.63%) (56.36%)
Return on assets (56.87%) (20.32%) (48.04%)
Return on invested capital 0.00% 2.73% 0.00%

Growth

Metric CRBU HYPD Biotechnology median
Revenue growth (TTM) 10.02% 1,990.60% 6.02%
EPS growth (last fiscal year) 3.64% 84.28% 30.26%
Revenue growth, 5-year CAGR (2.03%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRBU HYPD Biotechnology median
Debt to equity 0.00 0.08 0.00
Current ratio 6.49 2.34 4.72
Net debt to EBITDA 0.96 (0.03) 0.96

Dividend

Metric CRBU HYPD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CRBU HYPD Biotechnology median
Market cap 49.82m 48.95m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack